Inclusion completed

A Phase I/II Trial and TG01 Gemcitabine as Adjuvant Therapy for Treating Patients with Resected Adenocarcinoma of the Pancreas

Cancer type: Pancreatic cancer

Phase: I/II

Principal Investigator: Dueland Svein

Country: NO

Keywords: Norway, Gemcitabine, TG01, Targovax, Oslo

Status: Inclusion completed